ORMDL3 and Allergy: ORMDL3 inhibits the rate-limiting enzyme serine palmitoyl CoA transferase in the de novo sphingolipid synthesis [100], which results in decreased sphingolipid synthesis and increased airway hyperreactivity, independent of allergy or inflammation in mouse models [101].